CHG

511

+2.3%↑

CHG

511

+2.3%↑

CHG

511

+2.3%↑

CHG

511

+2.3%↑

CHG

511

+2.3%↑

Search

Halma PLC

Gesloten

SectorIndustrieën

3,866 3.92

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3860

Max

3890

Belangrijke statistieken

By Trading Economics

Inkomsten

107M

187M

Verkoop

651M

1.2B

K/W

Sectorgemiddelde

39.217

47.787

EPS

0.553

Dividendrendement

0.67

Winstmarge

15.096

Werknemers

9,000

EBITDA

184M

317M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-0.61% downside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.67%

2.01%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-166M

14B

Vorige openingsprijs

3862.08

Vorige sluitingsprijs

3866

Halma PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 feb 2026, 23:21 UTC

Acquisities, Fusies, Overnames

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 feb 2026, 23:45 UTC

Marktinformatie

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 feb 2026, 23:40 UTC

Marktinformatie

Gold Falls on Possible Position Adjustments -- Market Talk

15 feb 2026, 23:06 UTC

Winsten

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 feb 2026, 23:04 UTC

Winsten

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 feb 2026, 23:04 UTC

Winsten

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 feb 2026, 23:01 UTC

Winsten

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 feb 2026, 23:01 UTC

Winsten

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 feb 2026, 22:58 UTC

Winsten

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 feb 2026, 22:53 UTC

Acquisities, Fusies, Overnames

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 feb 2026, 22:53 UTC

Acquisities, Fusies, Overnames

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 feb 2026, 22:52 UTC

Acquisities, Fusies, Overnames

Qube Shareholders to Receive A$5.20/Share in Cash

15 feb 2026, 22:52 UTC

Acquisities, Fusies, Overnames

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 feb 2026, 21:35 UTC

Winsten

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 feb 2026, 19:19 UTC

Acquisities, Fusies, Overnames

An S&P Global International Insider Bought Up Stock -- Barrons.com

14 feb 2026, 22:02 UTC

Winsten

Looking for Dividends? Consider Europe. -- Barrons.com

14 feb 2026, 09:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

13 feb 2026, 21:57 UTC

Winsten

Stocks Rise on Softer Inflation Data, but AI Jitters Trigger Worst Week Since November -- WSJ

13 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

13 feb 2026, 21:20 UTC

Winsten

Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More Stock Market Movers -- Barrons.com

13 feb 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Constellation Software: Lumine Group Completes Acquisition of Synchronoss Technologies >CSU.T SNCR

13 feb 2026, 20:45 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

13 feb 2026, 20:45 UTC

Marktinformatie

Dollar Pares Down Early Losses -- Market Talk

13 feb 2026, 20:39 UTC

Marktinformatie

Potential for Mild Winter Ahead Sinks Natural Gas for Week -- Market Talk

13 feb 2026, 20:28 UTC

Marktinformatie

Oil Settles Week Lower -- Market Talk

13 feb 2026, 19:51 UTC

Winsten

These Stocks Are Today's Movers: Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More -- Barrons.com

13 feb 2026, 19:32 UTC

Marktinformatie

Gold and Silver Climb to Finish Week In Positive Territory -- Market Talk

13 feb 2026, 19:32 UTC

Marktinformatie

Gold and Silver Climb to Finish Week In Positive Territory -- Market Talk

13 feb 2026, 19:29 UTC

Winsten

Big Tech's Spending Spree Could Limit Buybacks and Dividends -- Barrons.com

13 feb 2026, 18:18 UTC

Acquisities, Fusies, Overnames

Exxon, Walmart and 9 Other Stocks That Are Soaring Because Cash Is King Again -- Barrons.com

Peer Vergelijking

Prijswijziging

Halma PLC Prognose

Koersdoel

By TipRanks

-0.61% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 3,852.31 GBX  -0.61%

Hoogste 4,280 GBX

Laagste 2,490 GBX

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor Halma PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

13 ratings

7

Buy

5

Hold

1

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat